HEPHL1
Basic information
Region (hg38): 11:94021354-94114208
Links
Phenotypes
GenCC
Source:
- pili torti-developmental delay-neurological abnormalities syndrome (Limited), mode of inheritance: Unknown
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Abnormal hair, joint laxity, and developmental delay | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Biochemical; Dermatologic; Musculoskeletal; Neurologic | 31125343 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HEPHL1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 9 | |||||
missense | 74 | 87 | ||||
nonsense | 4 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 0 | |||||
non coding | 2 | |||||
Total | 0 | 3 | 76 | 14 | 10 |
Variants in HEPHL1
This is a list of pathogenic ClinVar variants found in the HEPHL1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-94021375-C-T | not specified | Uncertain significance (Nov 10, 2021) | ||
11-94021412-T-C | not specified | Uncertain significance (Jan 31, 2024) | ||
11-94021468-G-T | not specified | Uncertain significance (Apr 19, 2023) | ||
11-94021492-C-T | not specified | Uncertain significance (Sep 25, 2023) | ||
11-94045706-C-G | not specified | Uncertain significance (Aug 16, 2021) | ||
11-94045717-G-A | not specified | Uncertain significance (Feb 21, 2024) | ||
11-94045721-T-G | not specified | Uncertain significance (Feb 07, 2023) | ||
11-94045730-G-T | not specified | Uncertain significance (May 09, 2023) | ||
11-94045743-C-T | HEPHL1-related disorder | Likely benign (Nov 16, 2019) | ||
11-94045744-G-A | not specified | Likely benign (Mar 18, 2024) | ||
11-94045759-C-T | not specified | Uncertain significance (Oct 18, 2021) | ||
11-94045787-C-G | Likely benign (Mar 01, 2023) | |||
11-94045789-G-C | not specified | Uncertain significance (Dec 21, 2022) | ||
11-94045801-T-G | not specified | Uncertain significance (Mar 15, 2024) | ||
11-94045866-C-T | Likely pathogenic (Apr 28, 2021) | |||
11-94045893-G-A | Uncertain significance (Nov 01, 2023) | |||
11-94063535-G-C | not specified | Uncertain significance (Feb 13, 2024) | ||
11-94063610-C-A | not specified | Uncertain significance (Feb 23, 2023) | ||
11-94063616-C-T | HEPHL1-related disorder | Likely benign (Nov 26, 2019) | ||
11-94063665-C-T | Likely benign (Nov 01, 2022) | |||
11-94064339-A-AATAG | Pili torti-developmental delay-neurological abnormalities syndrome | Likely pathogenic (-) | ||
11-94064363-G-T | not specified | Uncertain significance (Jun 18, 2024) | ||
11-94064373-G-A | HEPHL1-related disorder | Benign (Dec 05, 2019) | ||
11-94064415-G-C | not specified | Uncertain significance (Dec 16, 2023) | ||
11-94064417-T-C | not specified | Uncertain significance (Mar 22, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
HEPHL1 | protein_coding | protein_coding | ENST00000315765 | 20 | 92391 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.15e-34 | 0.0000470 | 124272 | 1 | 378 | 124651 | 0.00152 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.184 | 622 | 635 | 0.979 | 0.0000326 | 7663 |
Missense in Polyphen | 247 | 255.14 | 0.96809 | 3158 | ||
Synonymous | -0.606 | 248 | 236 | 1.05 | 0.0000131 | 2180 |
Loss of Function | 0.409 | 54 | 57.3 | 0.942 | 0.00000334 | 646 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00267 | 0.00267 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00434 | 0.00429 |
Finnish | 0.000975 | 0.000975 |
European (Non-Finnish) | 0.00121 | 0.00120 |
Middle Eastern | 0.00434 | 0.00429 |
South Asian | 0.00212 | 0.00206 |
Other | 0.00252 | 0.00248 |
dbNSFP
Source:
- Function
- FUNCTION: May function as a ferroxidase and may be involved in copper transport and homeostasis. {ECO:0000250}.;
- Pathway
- Iron metabolism in placenta
(Consensus)
Intolerance Scores
- loftool
- 0.207
- rvis_EVS
- -0.28
- rvis_percentile_EVS
- 33.59
Haploinsufficiency Scores
- pHI
- 0.283
- hipred
- N
- hipred_score
- 0.197
- ghis
- 0.405
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.269
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Hephl1
- Phenotype
Gene ontology
- Biological process
- copper ion transport;iron ion transport;iron ion homeostasis;oxidation-reduction process
- Cellular component
- plasma membrane;integral component of membrane
- Molecular function
- ferroxidase activity;copper ion binding;oxidoreductase activity